Omalizumab in patients with severe uncontrolled asthma: well-defined eligibility criteria to promote asthma control

Omalizumab in patients with severe uncontrolled asthma: well-defined eligibility criteria to promote asthma control

Bibliographic Details
Main Authors:	Regina Maria de Carvalho-Pinto, Rosana Câmara Agondi, Pedro Giavina-Bianchi, Alberto Cukier, Rafael Stelmach
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Pneumologia e Tisiologia
Series:	Jornal Brasileiro de Pneumologia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132017000600487&lng=en&tlng=en

Similar Items

Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy
by: Hiroshi Odajima, et al.
Published: (2015-10-01)

Effectiveness of omalizumab in children and adolescents with uncontrolled allergic asthma: a case series from Poland
by: Anna Sztafińska, et al.
Published: (2021-07-01)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
by: C. C. Loureiro, et al.
Published: (2018-01-01)

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
by: Giovanna Elisiana Carpagnano, et al.
Published: (2021-03-01)

Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma
by: Hiroshi Odajima, et al.
Published: (2017-01-01)

Severe asthma and the omalizumab option
by: Johnston Chambless, et al.
Published: (2008-05-01)

Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients
by: A. Arrobas, et al.
Published: (2021-03-01)

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
by: Zafar Zafari, et al.
Published: (2018-01-01)

Real-world effectiveness and safety of omalizumab in patients with uncontrolled severe allergic asthma from the Czech Republic
by: Olga Růžičková Kirchnerová, et al.
Published: (2018-06-01)

Rhinitis and eosinophilic inflammation are prevalent in both allergic and non-allergic asthma
by: Pedro Giavina-Bianchi, et al.
Published: (2020-08-01)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
by: S. M. Snelder, et al.
Published: (2017-07-01)

Omalizumab for the treatment of severe persistent allergic asthma
by: J Jones, et al.
Published: (2009-09-01)

A review of omalizumab for the management of severe asthma
by: Lin CH, et al.
Published: (2016-07-01)

Omalizumab Treatment in Patients with Severe Allergic Asthma
by: Tuğba Songül Tat, et al.
Published: (2017-09-01)

The Role of Omalizumab in the Treatment of Severe Allergic Asthma
by: Kenneth R Chapman, et al.
Published: (2006-01-01)

Omalizumab in children with uncontrolled asthma: a real-life study carried out in Colombia
by: Olga Morales-Múnera, et al.
Published: (2018-07-01)

A Pharmaco-Economic Analyzis of Treating Severe Uncontrolled Child Asthma with Omalizumab — Actual Russian Clinical Practice Data
by: A. S. Kolbin, et al.
Published: (2016-11-01)

Appropriate selection for omalizumab treatment in patients with severe asthma?
by: Leo Nygaard, et al.
Published: (2017-01-01)

Omalizumab in patients with severe asthma and persistent sputum eosinophilia
by: Manali Mukherjee, et al.
Published: (2019-04-01)

Benefits of omalizumab on anxiety and depression in patients with severe asthma
by: Fatih Uzer, et al.
Published: (2018-05-01)

The role of omalizumab in the treatment of adults with severe allergic asthma
by: Sabina Škrgat Kristan
Published: (2013-02-01)

Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis
by: Carla Bisaccioni, et al.
Published: (2009-01-01)

The Long-Term Omalizumab Therapy in Children with Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry
by: Elena A. Vishneva, et al.
Published: (2018-05-01)

Omalizumab as add‐on therapy in a patient with severe asthma and OSA
by: Giulia Scioscia, et al.
Published: (2020-03-01)

Review: Omalizumab in the treatment of severe asthma: efficacy and current problems
by: Girolamo Pelaia, et al.
Published: (2008-12-01)

Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis
by: C. Incorvaia, et al.
Published: (2016-01-01)

Cluster Subanalysis of Patients With Severe Asthma Who Responded to Omalizumab
by: Almonacid Sánchez, C., et al.
Published: (2022)

Cutaneous Sarcoidosis in a Patient with Severe Asthma treated with Omalizumab
by: Samuel Yung, et al.
Published: (2015-01-01)

An algorithmic approach for the treatment of severe uncontrolled asthma
by: Eleftherios Zervas, et al.
Published: (2018-03-01)

Bronchial thermoplasty for severe uncontrolled asthma in Japan
by: Motoyasu Iikura, et al.
Published: (2018-04-01)

Omalizumab: Clinical Use for the Management of Asthma
by: Neil C. Thomson, et al.
Published: (2012-06-01)

Omalizumab: Clinical Use for the Management of Asthma
by: Neil C. Thomson, et al.
Published: (2012-01-01)

Difficult-to-control asthma management through the use of a specific protocol
by: Pedro Giavina-Bianchi, et al.
Published: (2010-01-01)

Dermatomyositis associated with omalizumab therapy for severe asthma: a case report
by: Samira Jeimy, et al.
Published: (2019-01-01)

Effects of Omalizumab Treatment on Some Biomarkers in Severe Allergic Asthma Patients
by: Seda Tural Önür, et al.
Published: (2017-08-01)

Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice
by: Eva Martínez-Moragón, et al.
Published: (2019-05-01)

Clinical experience with omalizumab in patients with severe asthma. Real-world data
by: Jorge Bernardo Vargas-Correa, et al.
Published: (2016-08-01)

Omalizumab in severe asthma: Evaluation of the clinical impact after its withdrawal
by: M. D. de Sousa, et al.
Published: (2017-03-01)

Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab
by: Francesco Menzella, et al.
Published: (2021-03-01)

Fluticasone furoate nasal spray in the treatment of allergic rhinitis
by: Pedro Giavina-Bianchi, et al.
Published: (2008-04-01)